Literature DB >> 25202976

Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight.

Laurie L Baggio, Daniel J Drucker.   

Abstract

The peptide hormone glucagon-like peptide-1 (GLP-1) enhances glucose-induced insulin secretion and inhibits both gastric emptying and glucagon secretion. GLP-1 receptor (GLP-1R) agonists control glycemia via glucose-dependent mechanisms of action and promote weight loss in obese and diabetic individuals. Nevertheless, the mechanisms and cellular targets transducing the weight loss effects remain unclear. Two recent studies in the JCI provide insight into the neurons responsible for this effect. Sisley et al. reveal that GLP-1R agonist-induced weight loss requires GLP-1Rs in the CNS, while Secher et al. reveal that a small peptide GLP-1R agonist penetrates the brain and activates a subset of GLP-1R-expressing neurons in the arcuate nucleus to produce weight loss. Together, these two studies elucidate pathways that inform strategies coupling GLP-1R signaling to control of body weight in patients with diabetes or obesity.

Entities:  

Year:  2014        PMID: 25202976      PMCID: PMC4191040          DOI: 10.1172/JCI78371

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.

Authors:  Stephanie Sisley; Ruth Gutierrez-Aguilar; Michael Scott; David A D'Alessio; Darleen A Sandoval; Randy J Seeley
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

Review 2.  Pharmacology, physiology, and mechanisms of incretin hormone action.

Authors:  Jonathan E Campbell; Daniel J Drucker
Journal:  Cell Metab       Date:  2013-05-16       Impact factor: 27.287

3.  Glucagon gene expression in vertebrate brain.

Authors:  D J Drucker; S Asa
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

4.  A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1.

Authors:  James T Patterson; Nickki Ottaway; Vasily M Gelfanov; David L Smiley; Diego Perez-Tilve; Paul T Pfluger; Matthias H Tschöp; Richard D Dimarchi
Journal:  ACS Chem Biol       Date:  2010-11-04       Impact factor: 5.100

5.  Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.

Authors:  Daniel J Drucker; John B Buse; Kristin Taylor; David M Kendall; Michael Trautmann; Dongliang Zhuang; Lisa Porter
Journal:  Lancet       Date:  2008-09-07       Impact factor: 79.321

6.  Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.

Authors:  K Meeran; D O'Shea; C M Edwards; M D Turton; M M Heath; I Gunn; S Abusnana; M Rossi; C J Small; A P Goldstone; G M Taylor; D Sunter; J Steere; S J Choi; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  1999-01       Impact factor: 4.736

7.  Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study.

Authors:  Richard E Pratley; Michael A Nauck; Anthony H Barnett; Mark N Feinglos; Fernando Ovalle; Illana Harman-Boehm; June Ye; Rhona Scott; Susan Johnson; Murray Stewart; Julio Rosenstock
Journal:  Lancet Diabetes Endocrinol       Date:  2014-02-06       Impact factor: 32.069

8.  Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling.

Authors:  Sarah H Lockie; Kristy M Heppner; Nilika Chaudhary; Joseph R Chabenne; Donald A Morgan; Christelle Veyrat-Durebex; Gayathri Ananthakrishnan; Françoise Rohner-Jeanrenaud; Daniel J Drucker; Richard DiMarchi; Kamal Rahmouni; Brian J Oldfield; Matthias H Tschöp; Diego Perez-Tilve
Journal:  Diabetes       Date:  2012-08-28       Impact factor: 9.461

9.  Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults.

Authors:  J van Can; B Sloth; C B Jensen; A Flint; E E Blaak; W H M Saris
Journal:  Int J Obes (Lond)       Date:  2013-09-03       Impact factor: 5.095

10.  Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake.

Authors:  Darleen A Sandoval; Didier Bagnol; Stephen C Woods; David A D'Alessio; Randy J Seeley
Journal:  Diabetes       Date:  2008-05-16       Impact factor: 9.461

View more
  35 in total

1.  A free-energy landscape for the glucagon-like peptide 1 receptor GLP1R.

Authors:  Raphael Alhadeff; Arieh Warshel
Journal:  Proteins       Date:  2019-08-02

2.  Imprinted Maternally Expressed microRNAs Antagonize Paternally Driven Gene Programs in Neurons.

Authors:  Amanda J Whipple; Vincent Breton-Provencher; Hannah N Jacobs; Udbhav K Chitta; Mriganka Sur; Phillip A Sharp
Journal:  Mol Cell       Date:  2020-02-06       Impact factor: 17.970

Review 3.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

4.  Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.

Authors:  Samar S M Elsheikh; Daniel J Müller; Jennie G Pouget
Journal:  Methods Mol Biol       Date:  2022

5.  Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery.

Authors:  Peng-Yu Yang; Huafei Zou; Elizabeth Chao; Lance Sherwood; Vanessa Nunez; Michael Keeney; Esi Ghartey-Tagoe; Zhongli Ding; Herlinda Quirino; Xiaozhou Luo; Gus Welzel; Guohua Chen; Parminder Singh; Ashley K Woods; Peter G Schultz; Weijun Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

Review 6.  Effects of Grape Seed Proanthocyanidin Extract on Obesity.

Authors:  Miao Liu; Peng Yun; Ying Hu; Jiao Yang; Rim Bahadur Khadka; Xiaochun Peng
Journal:  Obes Facts       Date:  2020-02-28       Impact factor: 3.942

7.  Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder.

Authors:  Gustavo A Angarita; David Matuskey; Brian Pittman; Jessica L Costeines; Marc N Potenza; Ania M Jastreboff; Heath D Schmidt; Robert T Malison
Journal:  Drug Alcohol Depend       Date:  2021-02-15       Impact factor: 4.492

Review 8.  Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism.

Authors:  Eun Roh; Do Kyeong Song; Min-Seon Kim
Journal:  Exp Mol Med       Date:  2016-03-11       Impact factor: 8.718

9.  Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment.

Authors:  Alok Sharma; Geetanjali Paliwal; Nisha Upadhyay; Archana Tiwari
Journal:  J Diabetes Metab Disord       Date:  2015-03-19

10.  The incretin hormone glucagon-like peptide 1 increases mitral cell excitability by decreasing conductance of a voltage-dependent potassium channel.

Authors:  Nicolas Thiebaud; Ida J Llewellyn-Smith; Fiona Gribble; Frank Reimann; Stefan Trapp; Debra Ann Fadool
Journal:  J Physiol       Date:  2016-04-13       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.